Pregnancy, High Risk Clinical Trials

15 recruiting

Pregnancy, High Risk Trials at a Glance

15 actively recruiting trials for pregnancy, high risk are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Columbus, Providence, and Los Angeles. Lead sponsors running pregnancy, high risk studies include Ohio State University, IRCCS San Raffaele, and University of Massachusetts, Worcester.

Browse pregnancy, high risk trials by phase

Treatments under study

About Pregnancy, High Risk Clinical Trials

Looking for clinical trials for Pregnancy, High Risk? There are currently 15 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Pregnancy, High Risk trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Pregnancy, High Risk clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 115 of 15 trials

Recruiting
Phase 4

Permissive Versus Strict Intrapartum Glucose Management in Type 1 Diabetes (PRISM-T1D)

Type 1 DiabetesPregnancy, High Risk
Ohio State University44 enrolled1 locationNCT07293715
Recruiting
Not Applicable

Early Detection of Gestational Diabetes Mellitus in Pregnancy

Pregnancy, High RiskGestational Diabetes Mellitus in Pregnancy
University of Massachusetts, Worcester80 enrolled1 locationNCT05388643
Recruiting
Phase 4

Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)

Pregnancy, High RiskPreterm BirthPreterm Premature Rupture of Membrane
Ohio State University56 enrolled2 locationsNCT06396078
Recruiting
Phase 4

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

Pregnancy, High RiskGestational Diabetes Mellitus
Ohio State University1,572 enrolled21 locationsNCT06445946
Recruiting
Phase 2Phase 3

Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women

DepressionAnxietyInflammation+9 more
Cedars-Sinai Medical Center150 enrolled1 locationNCT05552053
Recruiting
Not Applicable

A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE

Gestational DiabetesPregnancy, High RiskType2diabetes+3 more
Ohio State University104 enrolled1 locationNCT05909046
Recruiting
Phase 4

Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)

Pregnancy, High RiskAnticoagulants
University of California, Irvine12 enrolled1 locationNCT04861103
Recruiting
Not Applicable

Continuous Glucose Monitor Use in Pregnancy

Pregnancy, High RiskType 2 Diabetes Treated With Insulin
University of Massachusetts, Worcester180 enrolled1 locationNCT05317585
Recruiting

Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring

Pregnancy ComplicationsPregnancy RelatedPregnancy, High Risk
Sumitomo Pharma Switzerland GmbH728 enrolled1 locationNCT05739123
Recruiting
Not Applicable

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

Overweight and ObesityGestational DiabetesPregnancy, High Risk
Indiana University828 enrolled5 locationsNCT05124808
Recruiting

PRISMA Maternal and Newborn Health Study

Pregnancy, High Risk
George Washington University267,897 enrolled5 locationsNCT05904145
Recruiting

Medically Assisted Fertilization Techniques in Systemic Immunoreumatologic Diseases

Pregnancy ComplicationsFertility DisordersPregnancy, High Risk+2 more
IRCCS San Raffaele500 enrolled1 locationNCT05807256
Recruiting

Patients Pregnant Women With or Without Primary Antiphospholipid Antibody Syndrome

Pregnancy ComplicationsPreeclampsiaPregnancy, High Risk+3 more
IRCCS San Raffaele60 enrolled1 locationNCT05786235
Recruiting
Not Applicable

Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching

Pregnancy, High RiskType2diabetesPregnancy in Diabetic+1 more
Ohio State University124 enrolled1 locationNCT05662462
Recruiting

Commercial or Open Source Closed Loop Impact on Pregnancy Study

Type 1 DiabetesInsulin Dependent DiabetesPregnancy Related+1 more
University of California, San Francisco1,000 enrolled1 locationNCT06654713